🔎 Trials Near Me

Home › Myelofibrosis › Florida › Tampa

Myelofibrosis clinical trials in Tampa, FL

11 studies for Myelofibrosis are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07441694

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

RecruitingPhase 3
  • Moffit Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07623161

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07469891

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

RecruitingPhase 2
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06661915

A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms

RecruitingPhase 1
  • Site US04, Tampa
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07849231

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

RecruitingPhase 1/2
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT05320198

Pacritinib Effectiveness in Real-world Settings

RecruitingObservational study
  • Tampa General Hospital, Tampa
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT07774455

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

RecruitingPhase 2
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT05835466

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Tampa
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

RecruitingPhase 3
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Sep 25, 2025 · NCT06479135

Myelofibrosis trials in other cities

Other studies in Tampa

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.